Center for Transformational Psychotherapy https://ketaminepsychotherapy.com Ketamine and other psychotherapy practices Thu, 16 May 2024 18:52:06 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.3 https://ketaminepsychotherapy.com/wp-content/uploads/2018/03/cropped-FULL-png-32x32.png Center for Transformational Psychotherapy https://ketaminepsychotherapy.com 32 32 Lucid News – Awakening a Broad and Critical Understanding of Ketamine https://ketaminepsychotherapy.com/lucid-news-awakening-a-broad-and-critical-understanding-of-ketamine/ Thu, 16 May 2024 18:52:06 +0000 https://ketaminepsychotherapy.com/?p=2334 The Ketamine Research Foundation and its practitioner authors share our article for awakening a broad and critical understanding of the spectrum of benefits and hazards of ketamine’s use. As practitioners we are exposed to and probe the personal bases for ketamine’s extraordinary positive value to allay human suffering and for its dependence. We offer this work to increase knowledge about ketamine and ketamine assisted psychotherapy and to further compassionate awareness to individual susceptibilities and experiences. Our article is long and intricate in order to provide a full view.

And in Memory of Ken Jordan, who honored us with his deeply thoughtful editing, this as his last contribution.

https://www.lucid.news/about-ketamine-the-full-story-a-public-discourse/

]]> Dr. Phil Wolfson Featured in Oprah Daily Articles https://ketaminepsychotherapy.com/dr-phil-wolfson-featured-in-oprah-daily-articles/ Mon, 06 May 2024 22:20:02 +0000 https://ketaminepsychotherapy.com/?p=2328

There are a series of articles featuring the work of Dr. Phil Wolfson that recently appeared in the Oprah Daily magazine. The links to the articles are below.

The State of Psychedelics

Everything you need to know before and after taking the leap

The Most Unlikely Treatment for Eating Disorders

How I finally cracked my treatment resistant depression

]]> MDMA and Life-Threatening Illness study https://ketaminepsychotherapy.com/mdma-and-life-threatening-illness-study/ Fri, 09 Jun 2023 17:21:35 +0000 https://ketaminepsychotherapy.com/?p=2209 KRF is pleased to announce Wolfson, Andries, et al’s study of the MAPS sponsored MDMA and Life Threatening Illness,
this as KRF begins its study of KAP for Life-Threatening Illness.

Read the study here

]]> Read our Latest Paper https://ketaminepsychotherapy.com/read-our-latest-paper/ Fri, 09 Jun 2023 17:20:38 +0000 https://ketaminepsychotherapy.com/?p=2207 Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy

]]> We’ve been named the best Bay Area Ketamine Clinic https://ketaminepsychotherapy.com/weve-been-named-the-best-bay-area-ketamine-clinic/ Fri, 09 Jun 2023 17:20:21 +0000 https://ketaminepsychotherapy.com/?p=2205 CTP/Phil Wolfson named by Double Blind online mag as a best Bay Area Ketamine Clinic!

Read the article here

]]> New Yorker Article https://ketaminepsychotherapy.com/new-yorker-article/ Fri, 09 Jun 2023 17:19:29 +0000 https://ketaminepsychotherapy.com/?p=2203 Read the New Yorker Article that mentions our work here: Ketamine Therapy Is Going Mainstream. Are We Ready?

]]> Pharmacokinetics of Ketamine in Breast Milk https://ketaminepsychotherapy.com/pharmacokinetics-of-ketamine-in-breast-milk/ Fri, 09 Jun 2023 17:18:53 +0000 https://ketaminepsychotherapy.com/?p=2202 The Pharmacokinetics of Ketamine in the Breast Milk of Lactating Women: Quantification of Ketamine and Metabolites
 
just published online in the Journal of Psychoactive Drugs (click link above to read)

The Ketamine Research Foundation (KRF)is proud to present its research on the presence/absence of ketamine in breast milk. As a first line antidepressant, ketamine in assisted psychotherapy (KAP) for women who are breast-feeding and suffering with postpartum depression (PPD), and depression and PTSD offers the option for intermittent use. This solves the dilemma for women seeking effective treatment and who do not wish to expose infants to  continuous exposure to conventional treatments such as antidepressants. As the effects of long term continuous use of medication on infant development is unknown and difficult to study prospectively, the assurance of our study opens the door to a different and effective approach.

KRF is in the process of developing its protocol for PPD and we expect to launch in the Fall.

Contributions to our 501c3 Ketamine Research Foundation are deeply appreciated: ketamineresearchfoundation.org

]]>